• Wed, April 2, 2014
  • Tue, April 1, 2014
  • Thu, April 3, 2014
  • Mon, April 7, 2014
  • Tue, April 8, 2014
  • Fri, April 4, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $70 on, Apr 1st, 2014

Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $60 to $70 on, Apr 1st, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Upgraded from Sell to Hold and Held Target at $49 on, Friday, March 14th, 2014
  • David Risinger of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $52 on, Friday, March 14th, 2014
  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014